Summary
Satietin, a 50,000 dalton anorectic glycoprotein was isolated from human serum. Its isoelectric point is 7.0. It contains 14–15% amino acids and 70–75% carbohydrates. Its biological activity survives digestion with proteases and boiling.
Satietin is a highly potent anorectic substance. The intracerebro-ventricular administration of 10–20μg satietin suppresses food intake in rats during the first day of feeding after deprivation of food for 96 hours to half of the amount eaten by untreated controls (ID50). The onset of the effect can be detected within 30 minutes, the peak effect is reached within an hour. The effect lasts 24–30 hours.
Satietin acts both at intravenous and subcutaneous administration (ID50=0.5–0.75 mg/kg) in rats deprived of food for 96 hours. The peak effect is reached within an hour and lasts over 24 hours.
In contrast to the anorectic drugs in clinical use and to the endogenous anorectic substances (like cholecystokinin and calcitonin) satietin proved to be highly selective in suppressing food intake.
Considering that satietin is widely distributed in the world of vertebrates, its concentration in the blood is amazingly high, its site of effect is in the central nervous system and it induces satiety without having any other detectable central or peripheral effect, the hypothesis was forwarded that satietin may play the role of a rate limiting blood-borne satiety signal in the negative feedback of food intake,i.e. serving as the essential chemical link connecting the gastrointestinal tract and the brain in the regulation of feeding.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ahlskog, E., Hoebel, B. G.: Overeating and obesity from damage to a nor-adrenergic system in the brain. Science182, 166–168 (1973).
Anand, B. K., Brobeck, J. R.: Hypothalamic control of food intake in rats and cats. Yale Biol. Med.24, 123–140 (1951).
Anastasi, A., Erspamer, V., Bucci, M.: Isolation and structure of bombesin and alytesin, two analogous active peptides from the skin of the European amphibians Bombina and Alytes. Experientia27, 166–167 (1971).
Anika, S. M., Houpt, T. R., Houpt, K. A.: Insulin as a satiety hormone. Physiol. Behav.25, 21–23 (1980).
Antin, J., Gibbs, J., Holt, J., Young, R. C., Smith, G. P.: Cholecystokinin elicits the complete behavioral sequence of satiety in rats. J. comp. physiol. Psychol.89, 784–790 (1975).
Atkinson, R. L.: Naloxone decreases food intake in obese humans. J. Clin. Endocrinol. Metab.55, 196–198 (1982).
Baile, C. A., Simpson, C. W., Bean, S. M., Mclaughlin, C. L., Jacobs, H. L.: Prostaglandins and food intake of rats: A component of energy balance regulation? Physiol. Behav.10, 1077–1085 (1973).
Beach, F. A.: Relative effect of androgens upon the mating behavior of male rats subjected to forebrain injury or castration. Exp. Zool.97, 249–259 (1944).
Blundell, J. E.: Is there a role for serotonin (5-hydroxy-tryptamine) in feeding? Int. J. Obesity1, 15–42 (1977).
Blundell, J. E., McArthur, R. A.: Obesity and its Treatment, Vol. 1. Montreal: Eden Press. 1979.
Blundell, J. E., Latham, C. J.: Behavioral pharmacology of feeding. In: Drugs and Appetite (Silverstone, T., ed.), pp. 41–90. London: Academic Press. 1982.
Booth, D. A.: Amphetamine anorexia by direct action in the adrenergic feeding system of rat hypothalamus. Nature217, 869–870 (1968).
Brown, D. R., Holtzman, S. G.: Suppression of deprivation-induced food and water intake in rats and mice by naloxone. Pharmacol. Biochem. Behav.11, 567–573 (1979).
Della-Fera, M. A., Baile, C. A.: CCK-oktapeptide injected in CSF decreases meal size and daily food intake in sheep. Peptides1, 51–54 (1980).
Doggett, N. S., Jawaharlal, K.: Anorectic activity of prostaglandin precursors. Br. J. Pharmacol.60, 417–423 (1977).
Fonberg, E.: Amygdala functions within the alimentary system. Acta Neurobiol. Exp.34, 435–466 (1974).
Freed, W. J., Perlow, M. J., Wyatt, R. J.: Calcitonin: inhibitory effect on eating in rats. Science206, 850–852 (1979).
Frenk, H., Rogers, G. H.: The suppressant effects of naloxone on food and water intake in the rat. Behav. Neurol. Biol.26, 23–40 (1979).
Gambert, S. R., Garthwaite, T. L., Pontzer, C. H., Hagen, T. C.: Fasting associated with decrease in hypothalamic betaendorphin. Science210, 1271–1272 (1980).
Garcia, J., Hankins, W. G., Kenneth, R. W.: Behavioral regulation of the milieu interne in man and rat. Science185, 824–831 (1974).
Gibbs, J., Smith, G. P.: Cholecystokinin and satiety in rats and rhesus monkeys. Am. J. clin. Nutr.30, 758–761 (1977).
Gibbs, J., Young, R. C., Smith, G. P.: Cholecystokinin decreases food intake in rats. J. Comp. Physiol. Psychol.84, 488–495 (1973).
Gibbs, J., Falasco, J. D., McHugh, P. R.: Cholecystokinin-decreased food intake in rhesus monkeys. Am. J. Physiol.230, 15–18 (1976).
Gibbs, J., Fauser, D. J., Rowe, E. A., Rolls, B. J., Rolls, E. T., Madison, S. P.: Bombesin suppresses feeding in rats. Nature282, 208–210 (1979).
Grandison, S., Guidotti, A.: Stimulation of food intake by muscimol and beta-endorphin. Neuropharmacology16, 533–536 (1977).
Grossman, S. P.: Eating and drinking elicited by direct adrenergic and cholin-ergic stimulation of hypothalamus. Science132, 301–302 (1960).
Grossman, S. P.: Behavioural effects of direct chemical stimulation of central nervous system structures. Int. J. Neuropharmacol.3, 45–58 (1964).
Hetherington, A. W., Ranson, S. W.: Hypothalamic lesions and adiposity in the rat. Anat. Rec.78, 149–172 (1940).
Hoebel, B. G., Novin, D. (eds.): The Neuronal Basis of Feeding and Reward. Brunswick, Mass.: Haer Institute. 1982.
Hoebel, B. G., Hernandez, L., McLean, S.: Catecholamines, enkephalin and neurotensin in feeding and reward. In: The Neuronal Basis of Feeding and Reward (Ed.Hoebel, B. G., Novin, D., eds.) pp. 465–478. Brunswick, Mass.: Haer Institute. 1982.
Holtzman, S. G.: Behavioral effects of separate and combined administration of naloxone and d-amphetamine. J. Pharm. exp. Ther.189, 51–60 (1974).
Horton, E. W.: Actions of prostaglandins E1, E2 and E3 on the central nervous system. Br. J. Pharmacol. Chemother.22, 189–192 (1964).
Innis, R. B., Correa, F. M. A., Ukl, G. R., Schneider, B., Snyder, S. H.: Cholecystokinin octapeptide-like immunoreactivity: histochemical localization in rat brain. Proc. Natl. Acad. Sci. U.S.A.76, 521–525 (1979).
Issekutz, B., Issekutz, B., Jr.: Einfache Apparate zur Messung des Sauerstoffverbrauches von Versuchstieren. Arch. exp. Pathol. Pharmacol.199, 306–311 (1942).
Knoll, B., Knoll, J.: The selectivity of the anorectic effect of satietin. I. The ineffectiveness of satietin in behavioral tests. Pol. J. Pharmacol. Pharm.34, 17–23 (1982).
Knoll, B., Held, K., Knoll, J.: Rapid screening of drug action on learning and memory. In: Symposium on Pharmacology of Learning and Retention (Knoll, B., ed.), pp. 43–47. Budapest: Akademiai Kiado. 1974.
Knoll, B., Timar, J., Knoll, J.: Comparison of the anorectic effect of satietin, amphetamine and fenfluramine in raphe lesioned rats. Neurosci. Lett. Suppl.10, 269 (1982).
Knoll, J.: Theory of Active Reflexes. Budapest: Akademiai Kiado/New York: Hafner. 1969.
Knoll, J.: New aspects in the chemoregulation of food intake. Neurosci. Letts. Suppl.1, 55 (1978).
Knoll, J.: Satietin: A highly potent anorexogenic substance in human serum. Physiol. Behav.23, 497–502 (1979).
Knoll, J.: The anorexogenic effect of satietin in comparison to the effects of calcitonin, cholecystokinin and pGlu-His-GlyOH. Neurosci. Letts. Suppl.5, 317 (1980 a).
Knoll, J.: Highly selective peptide chalones in human serum. In: Modulation of Neurochemical Transmission (Vizi, E. S., ed.), pp. 97–125. Budapest: Akademiai Kiado/Pergamon Press. 1980 b.
Knoll, J.: Anorectic agents and satietin, an endogenous inhibitor of food intake. In CNS Pharmacology-Neuropeptides (Yoshida, H., Hagihari, Y., Ebashi, S., eds.), pp. 147–162. Oxford: Pergamon Press. 1982 a.
Knoll, J.: Satietin: endogenous regulation of food intake. In: Regulatory Peptides: from Molecular Biology to Function (Costa, E., Trabucchi, M., eds.), pp. 501–509. New York: Raven Press. 1982 b.
Knoll, J.: Satietin: a centrally acting potent anorectic substance with a long-lasting effect in human and mammalian blood. Pol. J. Pharmacol. Pharm.34, 3–16 (1982 c).
Knoll, J., Knoll, B.: Methode zur Untersuchung der spezifisch depressiven Wirkung von „Tranquilizern“ auf das Zentralnervensystem. Arzneimittel-Forsch.8, 330–333 (1958).
Knoll, J., Knoll, B.: Methode zur Untersuchung der spezifisch depressiven Wirkung von „Tranquilizern“ auf das Zentralnervensystem. 2. Mitteilung. Arzneimittel-Forsch.9, 633–636 (1959).
Knoll, J., Knoll, B.: The cumulative nature of the reserpine effect and the possibilities of inhibiting cumulation pharmacologically. Arch. Int. Pharmacodyn.148, 200–216 (1964).
Kruk, A. L., Zarrindast, M. R.: Mazindol anorexia is mediated by activation of dopaminergic mechanisms. Br. J. Pharmacol.58, 367–372 (1976).
Kyriakides, M., Silverstone, T., Jeffcoate, W., Laurence, B.: Effect of naloxone on hyperphagia in Prader-Willi syndrome. Lanceti, 876–877 (1980).
Leibowitz, S. F.: Brain catecholaminergic mechanisms for control of hunger. In: Hunger: Basic Mechanisms and Clinical Implications (Novin, D., Wyrwicka, W., Bray, G. A., eds.), pp. 1–18. New York: Raven Press. 1976.
Levine, A. S., Morley, J. E.: The effect of prostaglandins (PGE2 and PGF2a ) on food intake in rats. Pharmacol. Biochem. Behav.15, 735–738 (1981).
Lotter, E. C., Krinsky, R., McKay, J. M., Trenner, C. M., Porte, D. jr., Woods, C. S.: Somatostatin decreases food intake of rats and baboons. J. Comp. Physiol. Psych.95, 278–287 (1981).
Malaisse-Lagae, F., Carpentier, J. L., Patel, Y. C., Malaisse, W. J., Orci, L.: Pancreatic polypeptide: a possible role in the regulation of food intake in the mouse. Hypothesis. Experientia33, 915–918 (1977).
Margolis, R. U., Altszuler, N.: Insulin in the cerebrospinal fluid. Nature215, 1375–1376 (1967).
Margules, D. L., Moisset, B., Lewis, M. J., Shibuya, J., Pert, C. B.: Beta-endorphin is associated with overeating in genetically obese mice (ob/ob) and (fa/ fa). Science202, 988–991 (1978).
Marks-Kaufman, R., Kanarek, R. B.: Morphine selectively influences macronutrient uptake in the rat. Pharmacol. Biochem. Behav.12, 427–430 (1980).
Martin, J. R., Novin, D.: Decreased feeding in rats following hepatic-portal infusion of glucagon. Physiol. Behav.19, 461–466 (1977).
McCarthy, P. S., Dettmar, P. W., Lynn, A. G., Sanger, D. J.: Anorectic actions of the opiate antagonist naloxone. Neuropharmacology12, 1347–1349 (1981).
Morley, J. E., Levine, A. S.: Corticotropin releasing factor, grooming and in-gestive behavior. Life Sci.31, 1459–1460 (1982 a).
Morley, J. E., Levine, A. S.: The role of the endogenous opiates as regulators of appetite. Am. J. clin. Nutr.35, 757–761 (1982 b).
Morley, J. E., Levine, A. S., Prasad, C.: Histidyl-proline diketopiperazine decreases food intake in rats. Brain. Res.210, 475–478 (1981).
Morgane, P. J.: Alterations in the feeding and drinking behavior of rats with lesions in globi pallidi. Am. J. Psychol.201, 420–428.
Mueller, K., Hsiao, S.: Specificity of cholecystokinin satiety effect: reduction of food but not water intake. Pharmac. Biochem. Behav.6, 643–646 (1977).
Nagy, J., Kalasz, H., Knoll, J.: An improved method for the preparation of highly purified satietin samples from human serum. Pol. J. Pharmacol. Pharm.34, 47–52 (1982).
Nagy, J., Kalasz, H., Knoll, J.: Isolation and characterization of a highly selective anorexogenic substance by chromatography and electrophoresis. In: Chromatography and Mass Spectrometry in Biomedical Sciences 2 (Frigerio, A., ed.), pp. 421–432. Amsterdam: Elsevier. 1983.
Nance, D. M., Coy, D. H., Kastin, A. J.: Experiments with a reported anorexogenic tripeptide: Pyro-Glu-His-Gly-OH. Pharmacol. Biochem. Behav.11, 733–735 (1979).
Novin, D., Wyrwiczka, W., Bray, G. A. (eds.: Hunger: Basic Mechanisms and Clinical Implications. New York: Raven Press. 1976.
Oomura, Y.: Chemosensitive neuron in the hypothalamus related to food intake behavior. Japan J. Pharmacol.31, Suppl. 1, 1P-12P (1981).
Oomura, Y., Shimizu, N., Inokuchi, A., Sakata, T., Arase, K., Fujimoto, M., Fukushima, M., Tsutsui, K.: Regulation of feeding by blood borne hunger and satiety substances through glucose-sensitive neurons. 12th Annual Meeting of Society for Neuroscience, Vol. 8, Part 1. Minnesota, Minn., 1982.
Ostrowski, N. L., Rowland, N., Foley, T. L., Nelson, J. L., Reid, L. D.: Morphine antagonists and consummatory behaviors. Pharmacol. Biochem. Behav.14, 549–559 (1981).
Owen, O. E., Reichard, G. A., jr., Boden, G., Shuman, C. R.: Comparative measurements of glucose, beta-hydroxybutyrate, acetoacetate, and insulin in blood and cerebrospinal fluid during starvation. Metabolism23, 7–14 (1974).
Penick, S. D., Hinkle, L. E., jr.: Depression of food intake induced in healthy subjects by glucagon. New England J. Med.264, 893–897 (1961).
Perlow, M. J., Freed, W. J., Carman, J. S., Wyatt, R. J.: Calcitonin reduces feeding in man, monkey and rat. Pharmac. Biochem. Behav.12, 609–612 (1980).
Reichelt, K. L., Foss, I., Trygsted, O., Edmison, P. D., Johansen, J. H., Boler, J. B.: Humoral control of appetite. II. Purification and characterization of an anorexogenic peptide from human urine. Neuroscience3, 1207–1211 (1978).
Rizzo, A. J., Goltzman, D.: Calcitonin receptors in the central nervous system of the rat. Endocrinology108, 1672–1677 (1981).
Sakata, T., Oomura, Y., Fikushima, M., Tsutsui, K., Hashimoto, K., Kuhara, T. T., Matsumoto, I.: Circadian and long term variation of certain metabolites in fasted rat, implications. Brain. Res. Bull.5, Suppl. 4, 23–28 (1980).
Salter, J. M.: Metabolic effects of glucagon in the Wistar rat. Am. J. Clin. Nutr.8, 535–539 (1960).
Sandor, G., Knoll, J.: The selectivity of the anorectic effect of satietin. II. The ineffectiveness of satietin on the water intake in food deprived rats. Pol. J. Pharmacol. Pharm.34, 25–32 (1982).
Sanger, D. J.: Endorphinergic mechanism in the control of food and water intake. Appetite2, 193–208 (1981).
Scaramuzi, O. E., Baile, C. A., Mayer, J.: Prostaglandins and food intake of rats. Experientia27, 256–257 (1971).
Schally, A. V., Redding, R. W., Lucien, H. W., Meyer, J.: Enterogastrone inhibits eating by fasted rats. Science157, 210–211 (1967).
Schulman, J. L., Carleton, J. L., Whitney, G., Whitehorn, J. C.: Effect of glucagon on food intake and body weight in man. J. Appl. Physiol.11, 419–421 (1957).
Silverstone, T. (ed.): Drugs and Appetite. London: Academic Press. 1982.
Stellar, E.: The psychology of motivation. Psychol. Rev.61, 5–22 (1954).
Stern, J. J., Cudillo, C. A., Kruper, J.: Ventromedial hypothalamus and short-term feeding suppression by caerulein in male rats. J. comp. physiol. Psychol.90, 484–490 (1976).
Sternbach, H. A., Annito, W., Pottash, A. L. C., Gold, M. S.: Anorexic effects of naltrexone in man. Lanceti, 388–389 (1982).
Thompson, D. A., Welle, S. L., Lilavivat, U., Pinecand, L., Campbell, R. G.: Opiate receptors blockade in man reduces 2-deoxy-d-glucose-induced food intake but not hunger, thirst and hypothermia. Life Sci.31, 849–852 (1982).
Timar, J., Knoll, J.: The selectivity of the anorectic effect of satietin. III. The ineffectiveness of satietin on metabolic rate, body temperature and blood pressure. Pol. J. Pharmacol. Pharm.34, 33–39 (1982).
Ungerstedt, U.: Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigrostriatal dopamine system. Acta Physiol. Scand.82, Suppl. 367, 95–122 (1971).
Vijayan, E., McCann, S. M.: Suppression of feeding and drinking activity in rats following intraventricular injection of thyrotropin releasing hormone. Endocrinology100, 1727–1730 (1977).
Woods, S. C., Porte, D. jr.: The central nervous system, pancreatic hormone, feeding and obesity. Adv. Metab. Dis.9, 282–312 (1978).
Woods, S. C., Lotter, E. C., McKay, L. D., Porte, D. jr.: Chronic intracerebro-ventricular infusion of insulin reduces food intake and body weight in baboons. Nature282, 503–505 (1979).
Woods, S. C., West, D. B., Stein, L. J., McKay, L. D., Lotter, E. C., Porte, S. G., Kenney, N. J., Porte, D. jr.: Peptides and the control of meal size. Diabetologia20, 305–313 (1981).
Wanderweele, D. A., Pi-Sunyer, F. X., Novin, D., Bush, M. J.: Chronic insulin infusion suppresses food ingestion and body weight gain in rats. Brain Res. Bull.5, Suppl. 4, 7–11 (1980).
Yen, T. T., Dallo, J., Knoll, J.: The selectivity of the anorectic effect of satietin. IV. The ineffectiveness of satietin on the sexual performance of male CFY rats. Pol. J. Pharmacol. Pharm.34, 41–45 (1982).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Knoll, J. Satietin; a 50,000 dalton glycoprotein in human serum with potent, long-lasting and selective anorectic activity. J. Neural Transmission 59, 163–194 (1984). https://doi.org/10.1007/BF01250007
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01250007